Nanotechnology Now

Our NanoNews Digest Sponsors
Heifer International



Home > News > Small Cap Stock Newsletter Quality Stocks Daily 5/2/07

May 2nd, 2007

Small Cap Stock Newsletter Quality Stocks Daily 5/2/07

Abstract:
BioForce Nanosciences, Inc. (BFNH) closed today at $1.08 with 40,700 shares traded. (BFNH) has a 52 week trading range of $1.11 to $1.28

BioForce Nanosciences, Inc. announced today the March sale of the Nano eNabler(TM) molecular printer to Louisiana Tech University in Ruston, Louisiana. Louisiana Tech. Louisiana Tech will use the Nano eNabler technology to study the patterning of cells brain and stem in culture.

BioForce Nanosciences develops and commercializes nanotech tools and solutions for the life sciences. The company is also involved in the invention, research, and development of patented and patent-pending products.

Source:
transworldnews.com

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

Investments/IPO's/Splits

Daikin Industries becomes OCSiAl shareholder July 27th, 2021

180 Degree Capital Corp. Reports +14.2% Growth in Q1 2021, $10.60 Net Asset Value Per Share as of March 31, 2021, and Developments From Q2 2021 May 11th, 2021

INBRAIN Neuroelectronics raises over €14M to develop smart graphene-based neural implants for personalised therapies in brain disorders March 26th, 2021

180 Degree Capital Corp. Issues Second Open Letter to the Board and Shareholders of Enzo Biochem, Inc. March 26th, 2021

Interviews/Book Reviews/Essays/Reports/Podcasts/Journals/White papers/Posters

Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024

Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024

Nanotechnology: Flexible biosensors with modular design November 8th, 2024

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project